HARVARD BIOSCIENCE INC HBIO revenue by segment, product and geography
In its fiscal year ending 2025-12-31, HARVARD BIOSCIENCE INC reported revenue across 2 products and services; the largest, Instruments Equipment Software And Accessories, was $78.3M, 90.4% of the filed sum (-10.0% against the prior period in the same filing).
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Instruments Equipment Software And Accessories$78.3M90.4%-10.0% yoy
- Service Maintenance And Warranty Contracts$8.29M9.6%+15.6% yoy
Members sum to the consolidated $86.5M for this period.
- United States$39M45.0%-6.6% yoy
- EMEA$26.7M30.9%-6.0% yoy
- China$11M12.7%-17.5% yoy
- Asia Other$6.68M7.7%-5.9% yoy
- Americas Other$3.23M3.7%-10.3% yoy
Members sum to the consolidated $86.5M for this period.
- Instruments Equipment Software And Accessories$18.6M89.5%-6.5% yoy
- Service Maintenance And Warranty Contracts$2.19M10.5%+14.7% yoy
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
About these figures
Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.
Descriptive and educational; not investment advice. Methodology and data lineage.